These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21070885)

  • 1. Safety and reliability of the insertable Reveal XT recorder in patients undergoing 3 Tesla brain magnetic resonance imaging.
    Haeusler KG; Koch L; Ueberreiter J; Coban N; Safak E; Kunze C; Villringer K; Endres M; Schultheiss HP; Fiebach JB; Schirdewan A
    Heart Rhythm; 2011 Mar; 8(3):373-6. PubMed ID: 21070885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial.
    Hindricks G; Pokushalov E; Urban L; Taborsky M; Kuck KH; Lebedev D; Rieger G; Pürerfellner H;
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):141-7. PubMed ID: 20160169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submuscular implantation of insertable cardiac monitors improves the reliability of detection of atrial fibrillation.
    Bergau L; Sohns C; Sossalla S; Muñoz-Exposito P; Luethje L; Zabel M
    J Interv Card Electrophysiol; 2015 Mar; 42(2):143-9. PubMed ID: 25582428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.
    Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Turov A; Shirokova N; Karaskov A
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):823-31. PubMed ID: 21930653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: Results from the Reveal LINQ Usability Study.
    Sanders P; Pürerfellner H; Pokushalov E; Sarkar S; Di Bacco M; Maus B; Dekker LR;
    Heart Rhythm; 2016 Jul; 13(7):1425-30. PubMed ID: 26961298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation.
    McLellan AJ; Ling LH; Azzopardi S; Ellims AH; Iles LM; Sellenger MA; Morton JB; Kalman JM; Taylor AJ; Kistler PM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):834-40. PubMed ID: 25141860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
    Pokushalov E; Romanov A; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):274-9. PubMed ID: 23210695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor.
    Pedrote A; Arana-Rueda E; García-Riesco L; Sánchez-Brotons J; Durán-Guerrero M; Gómez-Pulido F; Arce-León A; Frutos-López M
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1075-82. PubMed ID: 23790041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological effects of MRI-detected brain lesions after left atrial catheter ablation for atrial fibrillation: long-term results of the MACPAF study.
    Herm J; Fiebach JB; Koch L; Kopp UA; Kunze C; Wollboldt C; Brunecker P; Schultheiss HP; Schirdewan A; Endres M; Haeusler KG
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):843-50. PubMed ID: 23989301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multielectrode Pulmonary Vein Isolation Versus Single Tip Wide Area Catheter Ablation for Paroxysmal Atrial Fibrillation: A Multinational Multicenter Randomized Clinical Trial.
    Boersma LV; van der Voort P; Debruyne P; Dekker L; Simmers T; Rossenbacker T; Balt J; Wijffels M; Degreef Y
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003151. PubMed ID: 27071830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COR trial: a randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation.
    Pérez-Castellano N; Fernández-Cavazos R; Moreno J; Cañadas V; Conde A; González-Ferrer JJ; Macaya C; Pérez-Villacastín J
    Heart Rhythm; 2014 Jan; 11(1):8-14. PubMed ID: 24103221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial volume at MRI is the main determinant of outcome after pulmonary vein isolation plus linear lesion ablation for paroxysmal-persistent atrial fibrillation.
    Montefusco A; Biasco L; Blandino A; Cristoforetti Y; Scaglione M; Caponi D; Di Donna P; Boffano C; Cesarani F; Coin D; Perversi J; Gaita F
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):593-8. PubMed ID: 20216228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation.
    Manganiello S; Anselmino M; Amellone C; Pelissero E; Giuggia M; Trapani G; Giordano B; Senatore G; Gaita F
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):697-702. PubMed ID: 24665920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.
    Brachmann J; Morillo CA; Sanna T; Di Lazzaro V; Diener HC; Bernstein RA; Rymer M; Ziegler PD; Liu S; Passman RS
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003333. PubMed ID: 26763225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.
    Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic brain lesions following laserballoon-based pulmonary vein isolation.
    Wissner E; Metzner A; Neuzil P; Petru J; Skoda J; Sediva L; Kivelitz D; Wohlmuth P; Weichet J; Schoonderwoerd B; Rausch P; Bardyszewski A; Tilz RR; Ouyang F; Reddy VY; Kuck KH
    Europace; 2014 Feb; 16(2):214-9. PubMed ID: 23933850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertable cardiac monitors: current indications and devices.
    Sakhi R; Theuns DAMJ; Szili-Torok T; Yap SC
    Expert Rev Med Devices; 2019 Jan; 16(1):45-55. PubMed ID: 30522350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.
    Gersak B; Pernat A; Robic B; Sinkovec M
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1059-66. PubMed ID: 22587585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miniaturized Reveal LINQ insertable cardiac monitoring system: First-in-human experience.
    Pürerfellner H; Sanders P; Pokushalov E; Di Bacco M; Bergemann T; Dekker LR;
    Heart Rhythm; 2015 Jun; 12(6):1113-9. PubMed ID: 25728756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kato S; Foppa M; Roujol S; Basha T; Berg S; Kissinger KV; Goddu B; Manning WJ; Nezafat R
    Int J Cardiol; 2016 Jan; 203():848-54. PubMed ID: 26599750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.